Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has ...

Treatment is therefore directed toward relief of symptoms and a reduction in the incidence of acute exacerbations. Within the past decade, major advances in management have been made in the ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

A study of older patients with chronic obstructive pulmonary disease (COPD) suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics was associated with similar ...

GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved ANORO™ ELLIPTA ...

Long-Acting Bronchodilators Up Cardiovascular Risk in COPD New use of either long-acting β-agonists or anticholinergics is associated with increased risks of cardiovascular events among older ...

Phase III trials have shown that once-daily Striverdi® Respimat® provided fast, remarkable and sustained improvements in lung function when given in addition to usual care in patients with moderate to ...

Please provide your email address to receive an email when new articles are posted on . New use of long-acting bronchodilators beta-agonists and anticholinergics for treatment of chronic obstructive ...

LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global bronchodilators market is expected to grow at a CAGR of close to 5% during the forecast period. This ...

Scientists have long found a possible link between anticholinergic drugs and an increased risk of dementia. A study published in the journal JAMA Internal Medicine on Monday suggests that the link is ...

A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and respiratory ...